Memantine vs Tofacitinib
Memantine vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Memantine and Tofacitinib.
Mechanism of Action
Memantine: Non-competitive NMDA receptor antagonist.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Memantine — 60-80 hours; Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Memantine — C12H21N; Tofacitinib — C16H20N6O.
Molecular Weight: Memantine — 179.3080 g/mol; Tofacitinib — 312.3700 g/mol.
Type: Memantine — Small molecule; Tofacitinib — Small molecule.